Showing results (301-310 of 388) with videos related to
Sort By:
Pageof 39
Lancet (London, England)|September 27, 2003
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trialJens Overgaard, Hanne Sand Hansen, Lena Specht, et al.Acta Oncologica (Stockholm, Sweden)|January 3, 2025
The clinical utility of circulating human papillomavirus across squamous cell carcinomasKaren-Lise G Spindler, Anne V Jakobsen, Jesper G Eriksen, et al.Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Kenneth Jensen, et al.Cancer Epidemiology|August 19, 2014
Completeness and validity in a national clinical thyroid cancer database: DATHYRCAStefano Christian Londero, Jes Sloth Mathiesen, Annelise Krogdahl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative GroupAnn S Knoop, Helle Knudsen, Eva Balslev, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2005
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyMarianne Nordsmark, Søren M Bentzen, Volker Rudat, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2015
The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell typesBrita Singers Sørensen, Anders Knudsen, Catja Foged Wittrup, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 19, 2016
The relative biological effectiveness of antiprotonsMichael H Holzscheiter, Jan Alsner, Niels Bassler, et al.Acta Oncologica (Stockholm, Sweden)|May 18, 2018
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trialLine Brøndum, Jan Alsner, Brita Singers Sørensen, et al.BMJ Open|November 17, 2025
At the epicentre: a qualitative study of how parents of a child with de novo retinoblastoma experience the diagnostic process and primary treatmentStina Lou, Kathrine Carstensen, Pernille Aakjær Mikkelsen, et al.Pageof 39